Procter & Gamble Hygiene and Health Care (500459) Q2 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 26/27 earnings summary
12 Nov, 2026Executive summary
Q2 FY27 revenue from operations was ₹114,508 lakh; profit before tax was ₹26,202 lakh and profit for the period was ₹19,584 lakh.
H1 FY27 revenue from operations was ₹203,654 lakh, with profit before tax of ₹43,165 lakh and profit for the period of ₹32,211 lakh.
Financial highlights
Q2 FY27 total income was ₹114,885 lakh, compared with ₹116,007 lakh in Q2 FY26; total expenses were ₹87,829 lakh.
H1 FY27 total income was ₹203,654 lakh and total expenses were ₹163,133 lakh; H1 FY26 profit before tax was ₹54,648 lakh and profit for the period was ₹40,192 lakh.
Q2 FY27 income tax expense was ₹6,618 lakh; H1 FY27 income tax expense was ₹10,954 lakh.
Segment performance
Health Care Products and Hygiene Products were aggregated into one reportable segment covering the manufacture, trading and marketing of health and hygiene products.
Latest events from Procter & Gamble Hygiene and Health Care
- Revenue up 7% and operational profit up 19% year-over-year, led by innovation in core brands.500459
Q4 23/24 - 9-month revenue reached ₹3,374 crore with strong profit and portfolio growth.500459Q4 24/25
- Revenue and profit declined year-over-year, with all operations under a single segment.500459Q1 26/27
- Profit up 19% on flat sales, led by innovation, efficiency, and rapid growth in new segments.500459Investor Day 2026
- FY26 saw robust revenue and profit growth, with a ₹60 dividend and clean audit opinion.500459Q4 25/26
- Strong quarterly growth and a special dividend highlight robust performance.500459Q3 25/26
- Net profit and revenue increased year-over-year, with a Rs. 65 per share dividend proposed.500459Transition period
- Strong growth, innovation, and digital expansion drive positive outlook.500459Investor Update
- Q2 FY25 saw strong revenue and profit growth, with EPS up to ₹65.28.500459Q1 24/25